UK Brain Cancer Research: New Government Commitments
UK brain cancer research
UK Government Announces New Commitments to Brain Cancer Research
The UK Government has announced new commitments to improve brain cancer research, increase access to clinical trials and help patients benefit from new treatments sooner.
The announcement, made on 14 October 2026, follows a meeting between Prime Minister Andy Burnham and brain cancer campaigner Archie Goodburn, whose calls for greater investment and faster progress have helped bring renewed attention to the challenges facing people affected by brain tumours.
For patients, families and charities across the UK, the announcement represents an important opportunity for progress. However, the real impact will depend on how these commitments are delivered.
Types of Brain Tumours
Early diagnosis matters.
Four key commitments
What Has the Government Announced?
The Government has outlined four measures intended to accelerate progress in brain cancer research and treatment.
A new expert review of brain cancer research
An immediate review will examine progress since the Government’s previous review in 2018.
Led by Professor Anthony Chalmers, the review is expected to report within three months and identify the barriers preventing research developments from reaching patients.
A national action plan
The findings will inform a national action plan aimed at helping promising new treatments move from research laboratories into clinical practice more quickly.
A dedicated national brain cancer clinical lead
The Department of Health and Social Care has committed to appointing a national clinical lead to help coordinate efforts to improve brain cancer research and treatment.
Faster review of rare cancer medicine regulations
The Government has also asked the Medicines and Healthcare products Regulatory Agency (MHRA) to accelerate its review of regulations affecting medicines for rare conditions.
The review, required under the Rare Cancers Act 2026, is now expected to take two years rather than three.
Making a Difference Together
Support Families Affected by Brain Tumours
Better research matters. However, families also need clear advice, support and community right now. Explore our Help & Advice page or support our work today.
What It Means for Patients
What Could This Mean for Brain Tumour Patients?
One of the most encouraging aspects of the announcement is the focus on improving access to clinical trials.
Clinical trials play an important role in developing and testing new treatments. However, opportunities to participate can be limited, particularly for people diagnosed with rare or aggressive brain tumours.
The Government has committed to working with patients, families, researchers and charities to identify ways of increasing participation in clinical trials.
These measures do not mean new treatments will become available immediately. Nevertheless, improving research coordination and removing barriers could help create more opportunities for patients in the future.
The Need for Change
Why Continued Progress Matters
Brain tumours can have a devastating impact on individuals and families, and progress in developing treatments for some types has been limited.
While research continues to advance, there remains an urgent need for better treatment options, earlier diagnosis and improved support for people living with the effects of brain tumours.
At The Three Tumours, we welcome developments that recognise these challenges and put the needs of patients and families at the centre of future decisions.
We also recognise that announcements are only the beginning.
Meaningful progress will depend on sustained investment, collaboration and action that makes a genuine difference to people’s lives.
Living with a Brain Tumour: Where to Find the Right Support
How Families Affected by Brain Tumours Can Find Support
Behind every research announcement are individuals and families hoping for better outcomes, more treatment options and a brighter future.
At The Three Tumours, we remain committed to raising awareness, sharing information and supporting people affected by brain tumours.
We will continue following developments in brain cancer research and sharing important updates with our community.
If you or someone you love has been affected by a brain tumour, visit our Help & Advice section for further information and support.
Your questions, answered simply
Frequently Asked Questions About UK Brain Cancer Research
Helpful answers from our brain tumour charity.
If you still have questions, please do get in touch.
What has the UK Government announced about brain cancer research?
In October 2026, the UK Government announced new commitments aimed at improving brain cancer research and helping new treatments reach patients sooner. These include an expert review of research progress, plans for better national coordination and measures intended to improve access to clinical trials. The announcement focuses on identifying barriers that have slowed progress and finding ways to address them.
Will new brain cancer treatments become available sooner?
The Government’s commitments aim to reduce delays in developing and assessing new treatments. However, this does not mean new medicines will become available immediately. Treatments must still undergo clinical testing and regulatory assessment to establish their safety and effectiveness. The impact of these changes will depend on how the proposed measures are implemented.
How can brain tumour patients access clinical trials in the UK?
Patients interested in clinical trials should speak to their consultant or specialist healthcare team. They can help identify whether any suitable trials are available based on factors such as tumour type, diagnosis, previous treatment and eligibility requirements.
What is the Rare Cancers Act 2026, and how does it relate to brain tumours?
The Rare Cancers Act 2026 is intended to improve research and treatment opportunities for people affected by rare cancers, including some rare brain cancers. It includes measures relating to clinical trial awareness and the assessment of treatments for rare conditions. The Government’s October announcement builds on this legislation by proposing further action to address barriers in brain cancer research.
Why is more research into brain tumours needed?
Brain tumours are complex, and different types can respond differently to treatment. Although progress has been made, treatment options remain limited for some forms of brain cancer. Continued research is essential to improve understanding, develop more effective treatments and investigate ways to improve outcomes and quality of life for patients.
